24/7 Patient Assistance: 760-405-8205

Howard J. West, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. West graduated from Harvard Medical School and studying on a Fulbright Scholarship, he received a degree in Experimental Biology from Cambridge University in the United Kingdom. Dr. Howard West studied as an intern and resident at Brigham and Women’s Hospital Boston affiliated to Harvard University. Since 2002 Dr. West has been practicing at the Swedish Cancer Institute with a specialty in lung cancer. He completed his specialty training in mesothelioma at the University of Washington Fred Hutchinson Cancer Research Center. Practicing at one of the country’s most respected cancer research institutes, Dr. West has helped develop very efficient treatment methods for lung cancer.

  • Education & Training


    Harvard Medical School

    Medical School


    Brigham and Womens Hospital



    University Of Washington School Of Medicine



    Fred Hutchinson Cancer Center


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Swedish Cancer Institute - Seattle

    Languages: English/Spanish

    (206) 386-2354

    1221 Madison St

    Seattle, Washington 98104

    Read More
  • Publications & Memberships

    Dr. Howard J. West has contributed to 4 publications.

    Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations

    Stewart DJ1, Martin-Ucar AE, Edwards JG, West K, Waller DA.

    See more >>

    Presentation of HOG Lun 01-24 / USO-023 on the Prescribing Plans of American Medical Oncologists for Patients with Stage IIIB Non-small Cell Lung Cancer

    Green, MR.West H, & Socinski, MA. Impact of the ASCO 2007 . J Thor Oncol 2009; 4: 983-987.

    See more >>

    Histologic considerations for individualized systemic therapy approaches for the management of non-small cell lung cancer.

    West H, Harpole D, & Travis W.CHEST, 2009: 136; 1112-1118

    See more >>

    Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small cell lung cancer

    West HL, Wakelee HA, Perry MC, Belt RJ, Chen R, & Obasaju C. : A phase II clinical trial. Annals of Oncology 2009; 20: 850 -856

    See more >>


    American Society of Clinical Oncology

    Society of Critical Care Medicine

    Southwestern Oncology Group